Topic

Blue Cross Blue Shield (BCBS Association)

A collection of 1330 issues

How to Get Enhertu (fam-trastuzumab deruxtecan-nxki) Covered by Blue Cross Blue Shield in New York: Complete Prior Authorization and Appeal Guide

Quick Answer: Getting Enhertu Covered by BCBS in New York Enhertu (fam-trastuzumab deruxtecan-nxki) requires prior authorization from Blue Cross Blue Shield plans in New York for HER2-positive breast cancer, NSCLC, and gastric cancer. Key requirements include documented HER2 status (IHC 3+ or ISH amplified), prior trastuzumab-based therapy failure, and NCCN
6 min read

How to Get Zolgensma (onasemnogene abeparvovec-xioi) Covered by Blue Cross Blue Shield in California: Prior Authorization Guide, Appeals Process, and Success Strategies

Answer Box: Fast Track to Zolgensma Coverage Blue Shield of California requires prior authorization for Zolgensma with specific clinical criteria: confirmed SMA diagnosis via genetic testing, age under 2 years, ≤3 SMN2 gene copies, and no advanced disease. Submit through AuthAccel portal with genetic documentation. If denied, file internal appeal
5 min read

How to Get Ocrevus (Ocrelizumab) Covered by Blue Cross Blue Shield in Pennsylvania: Complete Timeline and Appeals Guide

Answer Box: Getting Ocrevus Covered by Blue Cross Blue Shield in Pennsylvania Blue Cross Blue Shield Pennsylvania requires prior authorization for Ocrevus (ocrelizumab) with specific clinical criteria: confirmed MS diagnosis, age 18+, negative hepatitis B screening, and documentation of prior DMT trials or contraindications. Submit PA requests through your plan&
6 min read